Two more pediatricians on NIAID's new advisory panel

Article

Two of the five new additions to the advisory council of the National Institute of Allergy and Infectious Diseases are pediatricians: Ann Arvin, MD, and Christel Uittenbogaart, MD....

Recent Videos
Jenna Marcovitz, MA explains how music therapy helps in pediatric care
Peter S. Jensen, MD
Suzanne Hollander, MS, RD, LDN, Senior Clinical Nutrition Specialist, Boston Children's Hospital | Image credit: Boston Children's
Joshua Feder, MD
Zika-based therapy for metastatic neuroblastoma with Tamarah Westmoreland, MD and Joseph Mazar, PhD | Image Credit: © Nemours- © Nemours - stock.adobe.com.
Geetika Kennady, MD, FAAP
Jillian Cotter, MD
Related Content
Data highlights motor function improvements with ELEVIDYS treatment | Image Credit: © Colored Lights - © Colored Lights - stock.adobe.com.

Duchenne muscular dystrophy gene therapy demonstrates improved motor functions

Joshua Fitch, Senior Editor
May 16th 2025
Article

Delandistrogene moxeparvovec-rokl (ELEVIDYS) showed significant motor function improvements in 8- to 9-year-old Duchenne muscular dystrophy patients in part 2 of the phase 3 EMBARK study.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Nicotine pouch, dual e-cigarette use increases among youth | Image Credit: © Saepul - © Saepul - stock.adobe.com.

Nicotine pouch, dual e-cigarette use increases among youth

Joshua Fitch, Senior Editor
May 15th 2025
Article

Youth nicotine pouch use and dual use with e-cigarettes increased from 2023 to 2024, highlighting the need for stronger prevention and regulation efforts.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
USPSTF: Syphilis screening during pregnancy has 'substantial' net benefit | Image Credit: © Kostia - © Kostia - stock.adobe.com.

USPSTF: Syphilis screening during pregnancy has 'substantial' net benefit

Joshua Fitch, Senior Editor
May 14th 2025
Article

The nearly 4000 cases in 2023 were the highest number reported in over 30 years, the Task Force stated.

Inozyme Pharma

INZ-701 shows early promise in treating ENPP1 Deficiency in pediatric patients

Morgan Ebert, Managing Editor
May 14th 2025
Article

Safety, phosphate level gains, and immunogenicity data offer encouraging signals in the pivotal trial.

© 2025 MJH Life Sciences

All rights reserved.